MoneyWorks4Me

Hind Bio Science - Quaterly Results

31 Jan 2023 Evaluate
The sales surged to Rs. 3.18 millions, up 32.50% for the December 2022 quarter as against Rs. 2.40 millions during the corresponding quarter previous year.The Total Profit for the quarter ended December 2022 of Rs. 0.47 millions grew from Rs.-0.01 millionsOP of the company witnessed a marginal growth to 0.49 millions from 0.01 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 3.18 2.40 32.50 5.89 4.34 35.71 4.36 10.32 -57.75
Other Income 0.00 0.00 0.00 0.00 0.52 0.00 0.52 0.00 0.00
PBIDT 0.49 0.01 4800.00 -0.48 -1.26 -61.90 -5.05 -9.39 -46.22
Interest 0.01 0.01 0.00 0.02 0.03 -33.33 0.05 0.07 -28.57
PBDT 0.48 0.00 0.00 -0.50 -1.29 -61.24 -5.10 -9.46 -46.09
Depreciation 0.01 0.01 0.00 0.03 0.03 0.00 0.03 0.08 -62.50
PBT 0.47 -0.01 -4800.00 -0.53 -1.32 -59.85 -5.13 -9.54 -46.23
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.03 -0.16 -118.75
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.01 200.00
PAT 0.47 -0.01 -4800.00 -0.53 -1.32 -59.85 -5.16 -9.38 -44.99
Equity 102.51 102.81 -0.29 102.51 102.81 -0.29 102.51 102.51 0.00
PBIDTM(%) 15.41 0.42 3597.82 -8.15 -29.03 -71.93 -115.83 -90.99 27.30
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..